Single-use bioreactor bags

Life sciences tools company (Marlborough, MA; wholly-owned by Danaher Corporation since $21.4B acquisition of GE Healthcare Life Sciences in 2020) that manufactures Whatman membrane filter papers and sterile filtration products alongside its dominant chromatography resin (Capto, Sephadex, Sepharose series) and bioreactor (WAVE, XDR) platforms. Cytiva is the successor to GE Healthcare Life Sciences and Amersham Biosciences. Whatman-branded products include nitrocellulose and mixed cellulose ester membranes used in sterile filtration, diagnostics, and laboratory applications. Cytiva's role in sterile filtration is secondary to Merck KGaA and Pall — Whatman filters are more prevalent in laboratory/QC applications than primary pharmaceutical manufacturing sterilization — but Cytiva's ownership alongside Pall within Danaher creates the world's most concentrated supply position in biopharmaceutical manufacturing consumables. Danaher's combined Pall + Cytiva platform spans filtration, chromatography, bioreactors, and cell culture media — covering essentially every critical consumable step in a biologics manufacturing process.

German laboratory and bioprocessing equipment company (Göttingen; XETRA: SRT; ~€3.4B revenue) that manufactures Sartopore 2 (PES — polyethersulfone) and Sartopore Platinum (modified PES) sterilizing membranes — the primary European alternative to Merck/Pall membrane platforms. Sartorius holds an estimated ~15% share of the pharmaceutical sterilizing filtration market, with particular strength in European biologics manufacturing. Sartorius also makes Sartocon cassette systems for tangential flow filtration (TFF), Stedim biocontainers (single-use bags), and Biowave bioreactor systems — making it, like Danaher, a vertically integrated supplier across multiple critical biopharmaceutical manufacturing unit operations. Sartorius acquired Stedim (France) in 2007 and has organically grown its bioprocessing portfolio. Göttingen primary manufacturing; additional production in Yauco, Puerto Rico (acquired via Sartorius Stedim Biotech).

Thermo Fisher Scientific (Waltham MA; NYSE: TMO; ~$43B revenue 2024) is the world's largest manufacturer of cell culture media through its Gibco brand — the dominant label in CHO (Chinese Hamster Ovary) cell culture media for biopharmaceutical manufacturing. Gibco CHO-S Serum-Free Medium, GlutaMAX supplement, CD CHO medium, and EX-CELL Advanced CHO media series supply the majority of global monoclonal antibody manufacturing processes. Thermo Fisher's cell culture media is manufactured primarily at its Grand Island, NY facility (acquired from Life Technologies, itself formerly GIBCO BRL), which is the single most important cell culture media manufacturing site in North America. Thermo Fisher also operates a major media production site in Paisley, Scotland (UK) that serves European biopharmaceutical manufacturing. Gibco media formulations are validated into more FDA-approved biologics manufacturing processes than any other supplier — creating regulatory lock-in equivalent to Cytiva's position in chromatography resins. The 2014 Thermo Fisher merger with Life Technologies (which itself had acquired Invitrogen in 2008 and GIBCO BRL in 2000) consolidated what were once multiple competing cell culture brands into a single dominant supplier.

German science and technology company (Darmstadt; family-owned since 1668; ~€22B revenue; XETRA: MRK) whose life sciences division (MilliporeSigma in North America) is the world's largest manufacturer of pharmaceutical-grade sterile filtration membranes and filter devices. Merck KGaA's filtration product lines include Durapore (PVDF, hydrophilic, 0.22 μm and 0.45 μm) — the dominant membrane for protein and buffer sterilization — and Millipore Express PLUS/SHC/SHR (PES/modified PES) for high-flow biopharmaceutical applications. Sterilizing filter devices (Millipak, Opticap XL) complete the product platform. Merck KGaA is estimated to hold ~35-40% of the global pharmaceutical sterilizing membrane market. Manufacturing is concentrated at Cork, Ireland (primary) and Jaffrey, NH and Billerica, MA (US). The Darmstadt parent that makes Durapore sterilizing filters also produces liquid crystals for LCD displays, OLED materials, photoresists for semiconductor lithography, and specialty chemicals for cosmetics — a 350-year-old German family business operating across pharmaceutical manufacturing and consumer display technology from the same corporate parent.

Saint-Gobain Performance Plastics (subsidiary of Saint-Gobain SA, Paris; Euronext: SGO; ~47.9B EUR revenue 2023; founded 1665) is the dominant multilayer film and flexible tubing supplier for single-use bioreactor bag manufacturers. Saint-Gobain's BioPharm Silicones and Fluid Systems division produces Tygon biopharmaceutical tubing, multilayer polyethylene film (PE/EVA/EVOH/PE structures for SU bag construction), and gamma-irradiation-compatible flexible container materials. The vast majority of SU bags sold by Cytiva, Sartorius, Thermo Fisher, and Merck KGaA use film or tubing from a small group of specialized film suppliers — and Saint-Gobain is the most significant of these. Saint-Gobain's film is manufactured to cell-culture-compatibility specifications: ultra-low extractables and leachables, validated gamma irradiation dose compatibility, and biological safety per USP Class VI and ISO 10993. The same Saint-Gobain divisions also supply films and tubing for pharmaceutical IV bags (saline, dextrose, parenteral nutrition) — a direct dual-use overlap with SU bioreactor bag manufacturing.